Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
Visesato Mor,Antonella Rella,Amir M. Farnoud,Ashutosh Singh,Mansa Munshi,Arielle M. Bryan,Shamoon Naseem,James B. Konopka,Iwao Ojima,Erika E. Büllesbach,Alan Ashbaugh,Michael J. Linke,Michael J. Linke,Melanie T. Cushion,Melanie T. Cushion,Margaret S. Collins,Hari Krishna Ananthula,Larry Sallans,Pankaj B. Desai,Nathan P. Wiederhold,Annette W. Fothergill,William R. Kirkpatrick,Thomas F. Patterson,Lai Hong Wong,Sunita Sinha,Guri Giaever,Corey Nislow,Patrick Flaherty,Xuewen Pan,Gabriele Vargas Cesar,Patricia de Melo Tavares,Susana Frases,Kildare Miranda,Kildare Miranda,Marcio L. Rodrigues,Marcio L. Rodrigues,Chiara Luberto,Leonardo Nimrichter,Maurizio Del Poeta +38 more
Reads0
Chats0
TLDR
Two compounds found were highly effective in vitro and in vivo against several pathogenic fungi and were well tolerated by animals and additive to current antifungals, suggesting that these drugs might pave the way for the development of a new class of antIFungals.Abstract:
Recent estimates suggest that >300 million people are afflicted by serious fungal infections worldwide. Current antifungal drugs are static and toxic and/or have a narrow spectrum of activity. Thus, there is an urgent need for the development of new antifungal drugs. The fungal sphingolipid glucosylceramide (GlcCer) is critical in promoting virulence of a variety of human-pathogenic fungi. In this study, we screened a synthetic drug library for compounds that target the synthesis of fungal, but not mammalian, GlcCer and found two compounds [ N ′-(3-bromo-4-hydroxybenzylidene)-2-methylbenzohydrazide (BHBM) and its derivative, 3-bromo- N ′-(3-bromo-4-hydroxybenzylidene) benzohydrazide (D0)] that were highly effective in vitro and in vivo against several pathogenic fungi. BHBM and D0 were well tolerated in animals and are highly synergistic or additive to current antifungals. BHBM and D0 significantly affected fungal cell morphology and resulted in the accumulation of intracellular vesicles. Deep-sequencing analysis of drug-resistant mutants revealed that four protein products, encoded by genes APL5 , COS111 , MKK1 , and STE2 , which are involved in vesicular transport and cell cycle progression, are targeted by BHBM. IMPORTANCE Fungal infections are a significant cause of morbidity and mortality worldwide. Current antifungal drugs suffer from various drawbacks, including toxicity, drug resistance, and narrow spectrum of activity. In this study, we have demonstrated that pharmaceutical inhibition of fungal glucosylceramide presents a new opportunity to treat cryptococcosis and various other fungal infections. In addition to being effective against pathogenic fungi, the compounds discovered in this study were well tolerated by animals and additive to current antifungals. These findings suggest that these drugs might pave the way for the development of a new class of antifungals.read more
Citations
More filters
Journal Article
Global Analysis of Protein Phosphorylation in Yeast
Jason Ptacek,Geeta Devgan,Gregory A. Michaud,Heng Zhu,Xiaowei Zhu,Joseph Fasolo,Hong Guo,Ghil Jona,Ashton Breitkreutz,Richelle Sopko,Rhonda R. McCartney,Martin C. Schmidt,Najma Rachidi,Soo-Jung Lee,Angie S. Mah,Lihao Meng,Michael J. R. Stark,David F. Stern,Claudio De Virgilio,Mike Tyers,Brenda J. Andrews,Mark Gerstein,Barry Schweitzer,Paul F. Predki,Michael Snyder +24 more
TL;DR: The in vitro substrates recognized by most yeast protein kinases are described, with the use of proteome chip technology, and these results will provide insights into the mechanisms and roles of protein phosphorylation in many eukaryotes.
Journal ArticleDOI
The antifungal pipeline: a reality check
TL;DR: The robust and dynamic antifungal pipeline is discussed, including results from preclinical academic efforts through to pharmaceutical industry products, and the targets, strategies, compounds and potential outcomes are described.
Journal ArticleDOI
The Still Underestimated Problem of Fungal Diseases Worldwide.
TL;DR: Concerns on the occurrence of a pandemic of fungal origin in a near future have been raised and to stop forgetting and underestimating fungal diseases is mandatory.
Journal ArticleDOI
New Horizons in Antifungal Therapy
Kaila M. Pianalto,J. A. Alspaugh +1 more
TL;DR: Together, the combined efforts of academic investigators and the pharmaceutical industry is resulting in exciting new possibilities for the treatment of invasive fungal infections.
Journal ArticleDOI
Antifungal Drugs: The Current Armamentarium and Development of New Agents
TL;DR: The authors' current arsenal of antifungals is described and current strategies that are being employed to improve the therapeutic safety and efficacy of these drugs are highlighted, including state-of-the-art approaches to discover novel chemical matter with antIfungal activity and some of the most promising new targets for antif fungus drug development.
References
More filters
Journal ArticleDOI
A rapid method of total lipid extraction and purification.
E. G. Bligh,W. J. Dyer +1 more
TL;DR: The lipid decomposition studies in frozen fish have led to the development of a simple and rapid method for the extraction and purification of lipids from biological materials that has been applied to fish muscle and may easily be adapted to use with other tissues.
Journal ArticleDOI
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna,Matthew Hanna,Eric Banks,Andrey Sivachenko,Kristian Cibulskis,Andrew Kernytsky,Kiran V. Garimella,David Altshuler,Stacey Gabriel,Mark J. Daly,Mark A. DePristo +10 more
TL;DR: The GATK programming framework enables developers and analysts to quickly and easily write efficient and robust NGS tools, many of which have already been incorporated into large-scale sequencing projects like the 1000 Genomes Project and The Cancer Genome Atlas.
Journal ArticleDOI
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo,Eric Banks,Ryan Poplin,Kiran V. Garimella,Jared Maguire,Christopher Hartl,Anthony A. Philippakis,Anthony A. Philippakis,Anthony A. Philippakis,Guillermo del Angel,Manuel A. Rivas,Manuel A. Rivas,Matt Hanna,Aaron McKenna,Timothy Fennell,Andrew Kernytsky,Andrey Sivachenko,Kristian Cibulskis,Stacey Gabriel,David Altshuler,David Altshuler,Mark J. Daly,Mark J. Daly +22 more
TL;DR: A unified analytic framework to discover and genotype variation among multiple samples simultaneously that achieves sensitive and specific results across five sequencing technologies and three distinct, canonical experimental designs is presented.
Related Papers (5)
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer,Damian J. Krysan +1 more